🟢 ICCM is trading 11.93% up today as U.S. ProSense installations jump 70%

ICCM is trading at $5.44 (+11.93%) in pre-market following a significant expansion of its ProSense system adoption in the U.S. market.

• The company reported a 70% rise in its active U.S. commercial installation base following recent FDA marketing authorization.
• Shares are currently on track for their best single-day performance in nearly five years amid a surge in investor attention.
• Market sentiment remains bullish, with analysts maintaining Buy or higher ratings as social message activity spikes.